TMO
Thermo Fisher Scientific Inc
658.00$
+0.9%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 59.0% | 63.7% | 59.2% | 58.8% | 59.0% | 60.8% | 59.0% | 59.4% | 58.8% | 59.0% | 59.3% | 58.8% | 59.0% | |
| 41.0% | 36.3% | 40.8% | 41.2% | 41.0% | 39.2% | 41.0% | 40.6% | 41.2% | 41.0% | 40.7% | 41.2% | 41.0% | |
| 3.0% | 3.0% | 3.2% | 3.2% | 3.3% | 3.3% | 3.3% | 3.2% | 3.1% | 2.9% | 3.1% | 3.0% | 3.0% | |
| 14.9% | 19.6% | 21.1% | 20.0% | 19.8% | 19.3% | 20.1% | 16.4% | 19.4% | 16.2% | 19.8% | 15.9% | 17.8% | |
| 22.3% | 18.0% | 24.1% | 24.5% | 22.9% | 19.3% | 23.4% | 23.0% | 22.5% | 22.2% | 23.7% | 23.8% | 23.1% | |
| 18.7% | 18.3% | 16.6% | 16.7% | 18.1% | 19.9% | 17.8% | 17.7% | 18.7% | 18.8% | 16.9% | 17.4% | 18.0% | |
| 3.7% | 4.1% | 3.5% | 4.0% | 4.0% | 3.4% | 2.9% | 3.7% | 3.1% | 3.0% | 3.2% | 3.3% | 3.2% | |
| 16.5% | 16.0% | 15.6% | 15.9% | 16.3% | 17.3% | 15.5% | 15.8% | 16.4% | 17.4% | 15.8% | 16.0% | 16.4% | |
| 0.5% | 1.2% | 2.7% | 1.2% | 0.9% | 1.3% | 0.9% | 0.8% | 1.9% | 1.3% | 0.6% | 1.4% | 1.3% | |
| 16.2% | 15.0% | 12.8% | 14.7% | 15.4% | 16.1% | 14.5% | 14.9% | 14.5% | 16.2% | 15.0% | 14.5% | 15.1% | |
| 28.5% | 27.8% | 26.9% | 28.2% | 27.4% | 26.9% | 25.4% | 25.8% | 25.5% | 26.3% | 21.0% | 21.4% | 23.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.